BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 22, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: New research identifies EBV antigen targets for MS therapies
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Cancer
BioWorld Science, Cancer
RSS
153Sm-EDTMP: further beneficial effects in prostate cancer patients with bone lesions
Nov. 7, 2000
Hemosol receives go-ahead to begin phase I study of HML-115
Nov. 7, 2000
Eukarion receives grant funds for SCS drug development
Nov. 7, 2000
Takeda's new GnRH antagonists, their production and use
Nov. 6, 2000
Kinase-inhibitory indolinone compounds patented by Sugen
Nov. 6, 2000
Novel antitumor alkaloid CWJ-a-5: pharmacokinetics in rats
Nov. 6, 2000
Idec files Zevalin BLA with FDA; European filing planned
Nov. 6, 2000
Degradation and stability of antitumor clinical candidate RH1 described at AAPS meeting
Nov. 6, 2000
Gilead begins phase II studies with liposomal formulation of lurtotecan
Nov. 6, 2000
International patent issued to DuPont for new MEK inhibitors
Nov. 3, 2000
Previous
1
2
…
3321
3322
3323
3324
3325
3326
3327
3328
3329
…
3719
3720
Next
RSS